ImageneBio, Inc. (IMA) KPIs and segments

IMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30

$3.45−0.27 (-7.26%)

Close on Nov 12, 2026Market cap $39.16MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive ImageneBio's business

Coming soon

This tab will track the numbers specific to ImageneBio's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?